8JM.F Vetoquinol S.A. A
Healthcare · Drug Manufacturers - Specialty & Generic
70.40
-0.14%
About the company
Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA operates as a subsidiary of Soparfin SCA.
52-week range
Dividend deep dive
Vetoquinol S.A. A, a company in the Drug Manufacturers - Specialty & Generic industry, currently offers a dividend yield of 1.32%. This is above its 5-year average yield of 0.83% and its 5-year high of 1.17%, suggesting it may be undervalued according to yield theory. The company's overall dividend rating score is not available. Neither a momentum score nor a value score is provided for intrinsic lenses.
Dividend history
Vetoquinol has maintained a dividend increase streak of 2 years. The 3-year dividend Compound Annual Growth Rate (CAGR) stands at 3.62%. A 5-year CAGR is not available. The company's recent dividend payments are 0.5 EUR in 2021, 0.8 EUR in 2022, 0.8 EUR in 2023, 0.85 EUR in 2024, and a projected 0.89 EUR in 2025. The dividend doubling time is 16 years, based on a CAGR of 4.49%.
Dividend safety
The dividend appears well-covered with a payout ratio of 18.83%. The company holds a current ratio of 3.08 and a quick ratio of 2.212, indicating strong liquidity. Total cash is 221,076,000 EUR against total debt of 15,292,000 EUR.
Quantic · Free
Read the rest of the safety verdict
Plus the key risks and what to watch next — free, no card.
AI-generated from Quantic's dividend data · Updated 16 Aug 2026 · Information, not financial advice.
Price history
Dividend profile
Yield band A stock's current dividend yield shown against its own range over the past five years — the low, average and high. Near the high end the shares look relatively cheap for the income they pay; near the low end, relatively expensive. It's the picture behind Dividend Yield Theory. Learn more → (5-year)
Payment calendar
Dividend history
Per-share dividend by year
Debt & leverage
Latest reported balance-sheet figures.
Held by 1 investor
Appears in these lists
8JM.F qualifies for these curated dividend rankings.
New to dividend investing?
Information, not financial advice.
Quantic · Free
Track 8JM.F and your whole portfolio
Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.
Need more? Pro adds portfolios, options income tracking & more AI. See Pro →